ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00534027
Recruitment Status : Completed
First Posted : September 24, 2007
Last Update Posted : January 14, 2016
Sponsor:
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2011
  Actual Study Completion Date : March 2011
  Certification/Extension First Submitted : December 14, 2015